Inhibiting the PI3K delta and gamma isoforms and prevents the activation of the PI3K/AKT‐mediated signaling pathway; this may lead to a reduction in cellular proliferation in PI3K delta/gamma‐expressing tumor cells. In addition, this agent modulates inflammatory responses through various mechanisms. This evidence concerns the gene AKT1 and neoplasm.